|
tbar.gif
Click
here to
submit entries
|
|
FDA Decisions on
Drug Approval Could Start Slipping
|
March
5, 2008--According to a BioCentury
story cited by In Vivo, the head of the FDA’s Office of New Drugs has
given unofficial permission for the office to miss deadlines on approval
decisions. The
Wall Street Journal Health Blog
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
